Global Cannabinoid Based Drug Discovery
Cannabinoid-based drug discovery and development refer to the scientific process of identifying, designing, and bringing to market medicines that act on the body’s endocannabinoid system (ECS) using compounds derived from Cannabis sativa (like THC and CBD), their synthetic analogs, or newly engineered molecules that target cannabinoid receptors (CB1, CB2) and related pathways.